Grants per year
Personal profile
Research Interests
General surgical pathology, Pulmonary pathology
Certifications and Licenses
| Anatomic Pathology | |
| Anatomic Pathology & Clinical Pathology |
Training Experience
| 1990 | Residency, Northwestern University, McGaw Medical Center (Northwestern Memorial Hospital) |
Education/Academic qualification
MD, Medicine, Gandhi Medical College
… → 1982
Research interests keywords
- Pathology
Fingerprint
Dive into the research topics where Anjana V Yeldandi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Grants
- 5 Finished
-
Core A: Administration
Sznajder, J. I. (PD/PI), Kwasny, M. J. (Co-PD/PI), Rademaker, A. W. (Co-PD/PI) & Yeldandi, A. V. (Co-PD/PI)
National Heart, Lung, and Blood Institute
4/1/09 → 4/30/15
Project: Research project
-
Pathophysiology of Alveolar Epithelial Lung Injury - Project 1: Effects of Hypoxia on the Alveolar Epithelium
Sznajder, J. I. (PD/PI), Budinger, G. S. (Co-PD/PI), Chandel, N. (Co-PD/PI), Glucksberg, M. R. (Co-PD/PI), Goldman, R. (Co-PD/PI), Kamp, D. W. (Co-PD/PI), Ridge, K. M. (Co-PD/PI), Sporn, P. H. (Co-PD/PI) & Yeldandi, A. V. (Co-PD/PI)
National Heart, Lung, and Blood Institute
8/1/03 → 5/31/08
Project: Research project
-
Pathophysiology of Alveolar Epithelial Lung Injury - Core A: Administration
Sznajder, J. I. (PD/PI) & Yeldandi, A. V. (Co-PD/PI)
National Heart, Lung, and Blood Institute
8/1/03 → 5/31/08
Project: Research project
-
Pathophysiology of Alveolar Epithelial Lung Injury - Project 1: Effects of Hypoxia on the Alveolar Epithelium
Sznajder, J. I. (PD/PI), Budinger, G. S. (Co-PD/PI), Chandel, N. (Co-PD/PI), Glucksberg, M. R. (Co-PD/PI), Goldman, R. (Co-PD/PI), Kamp, D. W. (Co-PD/PI), Ridge, K. M. (Co-PD/PI), Sporn, P. H. (Co-PD/PI) & Yeldandi, A. V. (Co-PD/PI)
National Heart, Lung, and Blood Institute
8/1/03 → 5/31/08
Project: Research project
-
Pathophysiology of Alveolar Epithelial Lung Injury - Core A: Administration
Sznajder, J. I. (PD/PI) & Yeldandi, A. V. (Co-PD/PI)
National Heart, Lung, and Blood Institute
8/1/03 → 5/31/08
Project: Research project
-
Distinctive evolution of alveolar T cell responses is associated with clinical outcomes in unvaccinated patients with SARS-CoV-2 pneumonia
The NU SCRIPT Study Investigators, 2024, (Accepted/In press) In: Nature Immunology.Research output: Contribution to journal › Article › peer-review
-
Neoadjuvant Therapy Before Resection of Primary Pulmonary Lymphoepithelial Carcinoma
Wu, E., Reznicek, J., Yeldandi, A. V., Patel, J. D. & Odell, D. D., Jun 2024, In: Clinical Lung Cancer. 25, 4, p. 376-379 4 p.Research output: Contribution to journal › Article › peer-review
-
Temporal correlation between postreperfusion complement deposition and severe primary graft dysfunction in lung allografts
Cerier, E., Kurihara, C., Kaiho, T., Toyoda, T., Manerikar, A., Kandula, V., Thomae, B., Yagi, Y., Yeldandi, A., Kim, S., Avella-Patino, D., Pandolfino, J., Perlman, H., Singer, B., Scott Budinger, G. R., Lung, K., Alexiev, B. & Bharat, A., Apr 2024, In: American Journal of Transplantation. 24, 4, p. 577-590 14 p.Research output: Contribution to journal › Article › peer-review
-
Uncommon molecular alterations in follicular-derived thyroid carcinoma: A single institution study
Alexiev, B. A., Vormittag-Nocito, E. R., Lorch, J., Yeldandi, A., Buttars, P. R. & Jennings, L. J., Jun 2024, In: Pathology Research and Practice. 258, 155355.Research output: Contribution to journal › Article › peer-review
-
Author Correction: Fibroblast A20 governs fibrosis susceptibility and its repression by DREAM promotes fibrosis in multiple organs (Nature Communications, (2022), 13, 1, (6358), 10.1038/s41467-022-33767-y)
Wang, W., Bale, S., Wei, J., Yalavarthi, B., Bhattacharyya, D., Yan, J. J., Abdala-Valencia, H., Xu, D., Sun, H., Goncalves Marangoni, R., Herzog, E., Berdnikovs, S., Miller, S. D., Sawalha, A. H., Tsou, P. S., Awaji, K., Yamashita, T., Sato, S., Asano, Y. & Tiruppathi, C. & 4 others, , Dec 2023, In: Nature communications. 14, 1, 523.Research output: Contribution to journal › Comment/debate › peer-review
Open Access
Datasets
-
Suppl_Fig._1 – Supplemental material for The JAK/STAT pathway is activated in systemic sclerosis and is effectively targeted by tofacitinib
Wang, W. (Creator), Bhattacharyya, S. (Creator), Marangoni, R. G. (Creator), Carns, M. (Creator), Dennis-Aren, K. (Creator), Yeldandi, A. (Creator), Wei, J. (Creator), Varga, J. (Creator) & Faivre, J. C. (Contributor), SAGE Journals, 2019
DOI: 10.25384/sage.9375521, https://sage.figshare.com/articles/figure/Suppl_Fig_1_Supplemental_material_for_The_JAK_STAT_pathway_is_activated_in_systemic_sclerosis_and_is_effectively_targeted_by_tofacitinib/9375521
Dataset
-
Suppl_Fig._2 – Supplemental material for The JAK/STAT pathway is activated in systemic sclerosis and is effectively targeted by tofacitinib
Wang, W. (Creator), Bhattacharyya, S. (Creator), Marangoni, R. G. (Creator), Carns, M. (Creator), Dennis-Aren, K. (Creator), Yeldandi, A. (Creator), Wei, J. (Creator), Varga, J. (Creator) & Keijdener, D. L. D. (Contributor), SAGE Journals, 2019
DOI: 10.25384/sage.9375524, https://sage.figshare.com/articles/figure/Suppl_Fig_2_Supplemental_material_for_The_JAK_STAT_pathway_is_activated_in_systemic_sclerosis_and_is_effectively_targeted_by_tofacitinib/9375524
Dataset
-
Suppl_Fig._3 – Supplemental material for The JAK/STAT pathway is activated in systemic sclerosis and is effectively targeted by tofacitinib
Wang, W. (Creator), Bhattacharyya, S. (Creator), Marangoni, R. G. (Creator), Carns, M. (Creator), Dennis-Aren, K. (Creator), Yeldandi, A. (Creator), Wei, J. (Creator), Varga, J. (Creator) & Sharma, N. (Contributor), SAGE Journals, 2019
DOI: 10.25384/sage.9375530, https://sage.figshare.com/articles/figure/Suppl_Fig_3_Supplemental_material_for_The_JAK_STAT_pathway_is_activated_in_systemic_sclerosis_and_is_effectively_targeted_by_tofacitinib/9375530
Dataset
-
The JAK/STAT pathway is activated in systemic sclerosis and is effectively targeted by tofacitinib
Wang, W. (Creator), Bhattacharyya, S. (Creator), Marangoni, R. G. (Creator), Carns, M. (Creator), Dennis-Aren, K. (Creator), Yeldandi, A. (Creator), Wei, J. (Creator) & Varga, J. (Creator), SAGE Journals, 2019
DOI: 10.25384/sage.c.4611566, https://sage.figshare.com/collections/The_JAK_STAT_pathway_is_activated_in_systemic_sclerosis_and_is_effectively_targeted_by_tofacitinib/4611566
Dataset